4-8867740-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_018942.3(HMX1):c.1000G>A(p.Ala334Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 1,289,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018942.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMX1 | NM_018942.3 | c.1000G>A | p.Ala334Thr | missense_variant | 2/2 | ENST00000400677.5 | NP_061815.2 | |
HMX1 | NM_001306142.2 | c.394+3481G>A | intron_variant | NP_001293071.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HMX1 | ENST00000400677.5 | c.1000G>A | p.Ala334Thr | missense_variant | 2/2 | 1 | NM_018942.3 | ENSP00000383516 | P1 | |
HMX1 | ENST00000506970.2 | c.394+3481G>A | intron_variant | 1 | ENSP00000446997 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152016Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000879 AC: 10AN: 1137798Hom.: 0 Cov.: 37 AF XY: 0.0000109 AC XY: 6AN XY: 548726
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152016Hom.: 0 Cov.: 33 AF XY: 0.0000539 AC XY: 4AN XY: 74246
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.1000G>A (p.A334T) alteration is located in exon 2 (coding exon 2) of the HMX1 gene. This alteration results from a G to A substitution at nucleotide position 1000, causing the alanine (A) at amino acid position 334 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 21, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 334 of the HMX1 protein (p.Ala334Thr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with HMX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1515302). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at